Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
REXO1, RNA exonuclease 1 homolog-like 12, pseudogene (REXO1L12P), is a human pseudogene located on chromosome 8q21.2[15]. As a pseudogene, it does not encode an active protein product and does not have known biological functions or involvement in clinical disease roles[1][3][5][9][15]. It is related by sequence homology to REXO1, an exonuclease gene, but has no established functional role, interacting drugs, or therapeutic relevance in current biomedical literature[3][5][9][15]. Key context - REXO1L12P is explicitly annotated as a pseudogene in major databases (HGNC, Alliance of Genome Resources, GeneCards)[3][5][15]. - There is no evidence it is a therapeutic target, drug-interacting gene, or clinically significant biomarker[3][5][9][15]. - It may be expressed at low levels in some cell types but is not known to produce a functional protein[9]. Note: Do not confuse this entry with the related but functional REXO1 gene, which does encode an active RNA exonuclease[13][16][17]. REXO1L12P does not share this function. For structured queries or target selection, this entry should generally be excluded as it refers to a non-coding pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on REX1, RNA exonuclease 1 homolog-like 12, pseudogene (REXO1L12P).